跳至主要内容
临床试验/JPRN-UMIN000040764
JPRN-UMIN000040764招募中未知

Evaluation of the effect of switching from LAMA / LABA therapy to ICS-containing triple therapy (ICS/LAMA/LABA) in patients with COPD. single center, real world study - The effect of switching from LAMA / LABA therapy to ICS / LAMA / LABA therapy in patients with COPD. single center, real world study

Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School0 个研究点目标入组 100 人开始时间: 2020年6月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Excluded from the study were those with a documented history of asthma, a bronchodilator response (BDR) to 400 microgram salbutamol shown as a FEV1 change of and or more than 200 ml or peripheral eosinophilia more than 150, presence of typical asthma symptoms of atopy or history of IgE more than 170IU/ml and those confirmed to have received LAMA, LABA or ICS other than the study drug or their combination.

研究者

发起方
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School

相似试验

已完成
不适用
Investigation of the effects of switching to a high genetic barrier protease inhibitor based regimen on low level viremia, immune activation and neurocognitive performance in patients on antiviral therapyaidsHIV1002146010047438
NL-OMON44785niversitair Medisch Centrum Utrecht65
招募中
不适用
The efficacy and safety of switching from linagliptin to once-weekly dulaglutide in hemodialysis patients with type 2 diabetes mellitus (pilot study)Type 2 diabetes mellitus
JPRN-UMIN000021944Minamisenju Hospital20
已完成
2 期
Is LMA applicable in cochlear implant?Condition 1: cochlear implant. Condition 2: Hearing Loss, Deafness.cochlear implant, Presence of otological and audiological implantsHearing Loss, Deafness
IRCT2013011512134N1Vice chancellor for research, Shahid Beheshti University of Medical Sciences , Loghman Hospital60
尚未招募
不适用
Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemia (Study on inpatients)type 2 diabetes
JPRN-UMIN000012458The Third Department of Internal Medicine(Department of Diabetes, Endocrinology and Metabolism),Tokyo Medical University30
尚未招募
不适用
Study of impact of switching from existing long-acting insulin to insulin degludec, a new long-acting insulin, on glycemic control and frequency of hypoglycemiatype 2 diabetes
JPRN-UMIN000012459The Third Department of Internal Medicine(Department of Diabetes, Endocrinology and Metabolism),Tokyo Medical University50